Nominations are open for GHTC's 2026 Innovating for Impact Awards.

Search the GHTC website

News

News
PATH/Patrick McKern
March 26, 2014

Devex covers launch of GHTC policy report

Devex reports on the launch of GHTC’s report Innovation for a changing world: The role of US leadership in global health R&D, which includes recommendations for US policymakers to advance global health R&D. GHTC Director Kaitlin Christenson is quoted, emphasizing the importance of sustained, long-term funding for global health R&D, as “there's no guarantee the tools we have today are going to help us meet the needs of tomorrow.”

Read time: 2 minutes / External link
PATH/Will Boase
March 26, 2014

GenomeWeb highlights findings from GHTC policy report, quotes GHTC staff

GenomeWeb explores key findings from GHTC’s report Innovation for a changing world: The role of US leadership in global health R&D, quoting GHTC Director Kaitlin Christenson and GHTC Policy Officer Ashley Bennett.

Read time: 6 minutes / External link
PATH/Will Boase
March 26, 2014

Recommendations from GHTC policy report highlighted in FierceBiotechResearch

Key policy recommendations from GHTC’s report Innovation for a changing world: The role of US leadership in global health R&D are highlighted in an article in FierceBiotechResearch, including the need for sustained funding for global health R&D and stronger roles for the US Agency for International Development and US Food and Drug Administration in advancing development of and access to new global health products.

Read time: 2 minutes / External link
PATH/Will Boase
March 26, 2014

Science Codex covers GHTC policy report launch

GHTC’s press release on the launch of its report Innovation for a changing world: The role of US leadership in global health R&D was picked up by Science Codex. The article highlights key findings from the report and policy recommendations for the US government, particularly the need for sustained funding and a strategic, coordinated approach to global health R&D. The article notes that recent budget cuts at the US National Institutes of Health—the largest funder of global health R&D—could jeopardize future progress against HIV/AIDS, tuberculosis, malaria, and neglected tropical diseases.

Read time: 5 minutes / External link